Charts
Peter Sandercock and IST-3Episode from the podcastPeter Sandercock and IST-3
Peter Sandercock and IST-3

Peter Sandercock and IST-3

Released Tuesday, 17th August 2010
Good episode? Give it some love!
Peter Sandercock and IST-3

Peter Sandercock and IST-3

Peter Sandercock and IST-3

Peter Sandercock and IST-3

Tuesday, 17th August 2010
Good episode? Give it some love!
Rate Episode
List
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript
spinner
Rate
List
Get this podcast via API

From The Podcast

Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischemic stroke within 3 hours of symptom onset. The International Stroke Trial or IST-3 seeks to determine whether a wider range of patients may benefit the International Journal of Stroke spoke to chief investigator Dr Peter Sandercock.

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more
Do you host or manage this podcast?
Claim and edit this page to your liking.
,
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More